These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 9315542)

  • 1. A prospective evaluation of catheter ablation of ventricular tachycardia as adjuvant therapy in patients with coronary artery disease and an implantable cardioverter-defibrillator.
    Strickberger SA; Man KC; Daoud EG; Goyal R; Brinkman K; Hasse C; Bogun F; Knight BP; Weiss R; Bahu M; Morady F
    Circulation; 1997 Sep; 96(5):1525-31. PubMed ID: 9315542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency catheter ablation of sustained ventricular tachycardia in idiopathic dilated cardiomyopathy.
    Kottkamp H; Hindricks G; Chen X; Brunn J; Willems S; Haverkamp W; Block M; Breithardt G; Borggrefe M
    Circulation; 1995 Sep; 92(5):1159-68. PubMed ID: 7648661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiofrequency catheter ablation of ventricular tachycardia following implantation of an automatic cardioverter defibrillator.
    Willems S; Borggrefe M; Shenasa M; Chen X; Hindricks G; Haverkamp W; Wietholt D; Block M; Breithardt G
    Pacing Clin Electrophysiol; 1993 Aug; 16(8):1684-92. PubMed ID: 7690937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Substrate Modification by Catheter Ablation on Implantable Cardioverter-Defibrillator Interventions in Patients With Unstable Ventricular Arrhythmias and Coronary Artery Disease: Results From the Multicenter Randomized Controlled SMS (Substrate Modification Study).
    Kuck KH; Tilz RR; Deneke T; Hoffmann BA; Ventura R; Hansen PS; Zarse M; Hohnloser SH; Kautzner J; Willems S;
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
    AbdelWahab A; Sapp J
    Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Success of Irrigated Radiofrequency Catheter Ablation of Sustained Ventricular Tachycardia: Post-Approval THERMOCOOL VT Trial.
    Marchlinski FE; Haffajee CI; Beshai JF; Dickfeld TL; Gonzalez MD; Hsia HH; Schuger CD; Beckman KJ; Bogun FM; Pollak SJ; Bhandari AK
    J Am Coll Cardiol; 2016 Feb; 67(6):674-683. PubMed ID: 26868693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catheter ablation of incessant ventricular tachycardia: acute and long-term results.
    Cao K; Gonska BD
    Eur Heart J; 1996 May; 17(5):756-63. PubMed ID: 8737107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial.
    Al-Khatib SM; Daubert JP; Anstrom KJ; Daoud EG; Gonzalez M; Saba S; Jackson KP; Reece T; Gu J; Pokorney SD; Granger CB; Hess PL; Mark DB; Stevenson WG
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):151-7. PubMed ID: 25332150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radiofrequency catheter ablation of ventricular tachycardia in patients with an implantable defibrillator. Long-term follow-up].
    Cabrera AM; Cordero AB; Rodríguez JA; Carmona JR; de Teresa Galván E
    Rev Esp Cardiol; 2005 May; 58(5):491-8. PubMed ID: 15899194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and relevance of nonreentrant monomorphic ventricular tachycardia in patients with frequent implantable cardioverter defibrillator interventions.
    Fiek M; Remp T; Fleckenstein M; Pohl T; Deiss M; Reithmann C
    J Interv Card Electrophysiol; 2015 Mar; 42(2):151-60. PubMed ID: 25620151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial.
    Kuck KH; Schaumann A; Eckardt L; Willems S; Ventura R; Delacrétaz E; Pitschner HF; Kautzner J; Schumacher B; Hansen PS;
    Lancet; 2010 Jan; 375(9708):31-40. PubMed ID: 20109864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Successful epicardial ablation of a postinfarction ventricular tachycardia].
    Gellér L; Szilágyi S; Zima E; Srej M; Szucs G; Molnár L; Merkely B
    Orv Hetil; 2008 Dec; 149(49):2335-9. PubMed ID: 19042186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ablation of postinfarction ventricular tachycardia guided by isolated diastolic potentials.
    Strohmer B; Hwang C
    Europace; 2003 Oct; 5(4):375-80. PubMed ID: 14753635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic catheter ablation for the prevention of defibrillator therapy.
    Reddy VY; Reynolds MR; Neuzil P; Richardson AW; Taborsky M; Jongnarangsin K; Kralovec S; Sediva L; Ruskin JN; Josephson ME
    N Engl J Med; 2007 Dec; 357(26):2657-65. PubMed ID: 18160685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catheter ablation of ventricular tachycardia in 136 patients with coronary artery disease: results and long-term follow-up.
    Gonska BD; Cao K; Schaumann A; Dorszewski A; von zur Mühlen F; Kreuzer H
    J Am Coll Cardiol; 1994 Nov; 24(6):1506-14. PubMed ID: 7930283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of ventricular tachycardia by transcatheter radiofrequency ablation in patients with ischemic heart disease.
    Kim YH; Sosa-Suarez G; Trouton TG; O'Nunain SS; Osswald S; McGovern BA; Ruskin JN; Garan H
    Circulation; 1994 Mar; 89(3):1094-102. PubMed ID: 8124795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unmappable ventricular tachycardia after an old myocardial infarction. Long-term results of substrate modification in patients with an implantable cardioverter defibrillator.
    Alzand BS; Timmermans CC; Wellens HJ; Dennert R; Philippens SA; Portegijs PJ; Rodriguez LM
    J Interv Card Electrophysiol; 2011 Aug; 31(2):149-56. PubMed ID: 21340515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catheter Ablation of Ischemic Ventricular Tachycardia With Remote Magnetic Navigation: STOP-VT Multicenter Trial.
    Skoda J; Arya A; Garcia F; Gerstenfeld E; Marchlinski F; Hindricks G; Miller J; Petru J; Sediva L; Sha Q; Janotka M; Chovanec M; Waldauf P; Neuzil P; Reddy VY
    J Cardiovasc Electrophysiol; 2016 Mar; 27 Suppl 1():S29-37. PubMed ID: 26969220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
    Sapp JL; Wells GA; Parkash R; Stevenson WG; Blier L; Sarrazin JF; Thibault B; Rivard L; Gula L; Leong-Sit P; Essebag V; Nery PB; Tung SK; Raymond JM; Sterns LD; Veenhuyzen GD; Healey JS; Redfearn D; Roux JF; Tang AS
    N Engl J Med; 2016 Jul; 375(2):111-21. PubMed ID: 27149033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.